IPCALAB.NS Balance Sheet
Ipca Laboratories Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹2,572.41 Cr. | ₹4,339.51 Cr. | ₹4,068.91 Cr. | ₹4,440.59 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹122.17 Cr. | ₹323.59 Cr. | ₹616.17 Cr. | ₹761.59 Cr. | CapitalWorkInProgress |
| Goodwill | ₹38.14 Cr. | ₹90.58 Cr. | ₹90.58 Cr. | ₹82.81 Cr. | Goodwill |
| Other Intangible Assets | ₹140.83 Cr. | ₹123.30 Cr. | ₹107.06 Cr. | ₹103.27 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹172.85 Cr. | ₹146.59 Cr. | ₹25.32 Cr. | ₹26.53 Cr. | NoncurrentInvestments |
| Other Non-current Assets | ₹52.16 Cr. | ₹183.60 Cr. | ₹237.95 Cr. | ₹252.98 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹3,437.16 Cr. | ₹5,562.38 Cr. | ₹5,492.01 Cr. | ₹5,993.33 Cr. | NoncurrentAssets |
| Inventories | ₹1,743.37 Cr. | ₹2,471.31 Cr. | ₹2,560.42 Cr. | ₹2,731.00 Cr. | Inventories |
| Trade Receivables | ₹989.02 Cr. | ₹1,686.51 Cr. | ₹1,873.82 Cr. | ₹2,014.26 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹1,257.85 Cr. | ₹208.91 Cr. | ₹167.17 Cr. | ₹437.12 Cr. | CashAndCashEquivalents |
| Current Investments | ₹323.32 Cr. | ₹558.40 Cr. | ₹763.39 Cr. | ₹633.42 Cr. | CurrentInvestments |
| Other Current Assets | ₹178.73 Cr. | ₹436.36 Cr. | ₹343.92 Cr. | ₹362.82 Cr. | OtherCurrentAssets |
| Total Current Assets | ₹5,189.27 Cr. | ₹5,535.55 Cr. | ₹5,967.04 Cr. | ₹6,373.61 Cr. | CurrentAssets |
| Total Assets | ₹8,626.43 Cr. | ₹11,101.28 Cr. | ₹11,760.55 Cr. | ₹12,370.19 Cr. | Assets |
| Equity Share Capital | ₹25.37 Cr. | ₹25.37 Cr. | ₹25.37 Cr. | ₹25.37 Cr. | EquityShareCapital |
| Other Equity | ₹5,816.65 Cr. | ₹6,306.82 Cr. | ₹6,923.08 Cr. | ₹8,038.44 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹5,842.02 Cr. | ₹6,332.19 Cr. | ₹6,948.45 Cr. | ₹8,063.81 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | ₹73.30 Cr. | ₹1,394.81 Cr. | ₹1,439.82 Cr. | ₹1,460.25 Cr. | NonControllingInterest |
| Total Equity | ₹5,915.32 Cr. | ₹7,727.00 Cr. | ₹8,388.27 Cr. | ₹9,524.06 Cr. | Equity |
| Long-term Borrowings | ₹651.78 Cr. | ₹580.41 Cr. | ₹543.24 Cr. | ₹109.12 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹905.29 Cr. | ₹1,018.64 Cr. | ₹986.06 Cr. | ₹539.20 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹805.75 Cr. | ₹807.09 Cr. | ₹758.46 Cr. | ₹594.82 Cr. | BorrowingsCurrent |
| Trade Payables | ₹525.06 Cr. | ₹776.08 Cr. | ₹846.17 Cr. | ₹940.29 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹69.02 Cr. | ₹122.23 Cr. | ₹86.78 Cr. | ₹87.46 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹1,805.82 Cr. | ₹2,355.64 Cr. | ₹2,384.29 Cr. | ₹2,306.93 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹8,626.43 Cr. | ₹11,101.28 Cr. | ₹11,760.55 Cr. | ₹12,370.19 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from IPCALAB.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).